Gene expression profiles of ABC transporters and cytochrome P450 3A in Caco-2 and human colorectal cancer cell lines

Pharmaceutical Research

Volumn 20, Issue 2, 2003, Pages 324-327

  Nakamura, Tsutomu ^a   Sakaeda, Toshiyuki ^a   Ohmoto, Nobuko ^a   Moriya, Yuka ^a   Komoto, Chiho ^a   Shirakawa, Toshiro ^a   Gotoh, Akinobu ^a   Matsuo, Masafumi ^a   Okumura, Katsuhiko ^a  

^a KOBE UNIVERSITY   (Japan)

Author keywords

In vitro screening model; MDR1; Multidrug resistance associated protein (MRP); Villin

Indexed keywords

ABC TRANSPORTER; CYTOCHROME P450 3A; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GLYCOPROTEIN P; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; VILLIN;

ARTICLE; CANCER CELL CULTURE; CELL LEVEL; CELL STRAIN CACO 2; COLORECTAL CANCER; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ARYL HYDROCARBON HYDROXYLASES; ATP-BINDING CASSETTE TRANSPORTERS; CACO-2 CELLS; COLORECTAL NEOPLASMS; CYTOCHROME P-450 CYP3A; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; OXIDOREDUCTASES, N-DEMETHYLATING; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0037331756     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022251910820     Document Type: Article

References (15)

1. X. Boulenc. Intestinal cell models: Their use in evaluating the metabolism and absorption of xenobiotics. S. T. P. Pharm. Sci. 7:259-269 (1997).
2. M. Pinto, S. Robine-Leon, M. D. Appay, M. Kedinger, N. Triadou, E. Dussaulx, B. Lacroix, P. Simon-Assmann, K. Haffen, J. Fogh, and A. Zweibaum. Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture. Biol. Cell 47:323-330 (1983).
3. I. J. Hidalgo and J. Li. Carrier-mediated transport and efflux mechanisms in Caco-2 cells. Adv. Drug Delivery Rev. 22:53-66 (1996).
4. P. Artursson and R. T. Borchardt. Intestinal drug absorption and metabolism in cell cultures: Caco-2 and beyond. Pharm. Res. 14:1655-1658 (1997).
5. P. B. Watkins. The barrier function of CYP3A4 and P-glycoprotein in the small bowel. Adv. Drug Deliv. Rev. 27:161-170 (1997).
6. V. Milovic, G. Ocklind, and P. Artursson. Conditionally immortalized intestinal epithelial cells. Ann. NY Acad. Sci. 859:201-203 (1998).
7. L. Z. Benet and C. L. Cummins. The drug effiux-metabolism alliance: Biochemical aspects. Adv. Drug Deliv. Rev. 50:S3-S11 (2001).
8. T. Hirohashi, H. Suzuki, X.-Y. Chu, I. Tamai, A. Tsuji, and Y. Sugiyama. Function and expression of multidrug resistance-associated protein family in human colon adenocarcinoma cells (Caco-2). J. Pharmacol. Exp. Ther. 292:265-270 (2000).
9. P. Schmiedlin-Ren, K. E. Thummel, J. M. Fisher, M. F. Paine, K. S. Lown, and P. B. Watkins. Expression of enzymatically active CYP3A4 by Caco-2 cells grown on extracellular matrix-coated permeable supports in the presence of 1α,25-dihydroxyvitamin D3. Mol. Pharmacol. 51:741-754 (1997).
10. C. L. Cummins, L. M. Mangravite, and L. Z. Benet. Characterizing the expression of CYP3A4 and effiux transporters (P-gp, MRP1, and MRP2) in CYP3A4-transfected Caco-2 cells after induction with sodium butyrate and the phorbol ester 12-otetradecanoylphorbol-13-acetate. Pharm. Res. 18:1102-1109 (2001).
11. H. A. Engman, H. Lennernäs, J. Taipalensuu, C. Otter, B. Leidvik, and P. Artursson. CYP3A4, CYP3A5, and MDR1 in human small and large intestinal cell lines suitable for drug transport studies. J. Pharm. Sci. 90:1736-1751 (2001).
12. T. Nakamura, T. Sakaeda, N. Ohmoto, T. Tamura, N. Aoyama, T. Shirakawa, T. Kamigaki, T. Nakamura, K. I. Kim, S. R. Kim, Y. Kuroda, M. Matsuo, M. Kasuga, and K. Okumura. Real-time quantitative polymerase chain reaction for MDR1, MRP1, MRP2, and CYP3A-mRNA levels in Caco-2 cell lines, human duodenal enterocytes, normal colorectal tissues and colorectal adenocarcinomas. Drug Metab. Dispos. 30:4-6 (2002).
13. K. S. Lown, R. R. Mayo, A. B. Leichtman, H. L. Hsiao, D. K. Turgeon, P. Schmiedlin-Ren, M. B. Brown, W. Guo, S. J. Rossi, L. Z. Benet, and P. B. Watkins. Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine. Clin. Pharmacol. Ther. 62:248-260 (1997).
14. R. W. Johnstone, A. A. Ruefli, and M. J. Smyth. Multiple physiological functions for multidrug transporter P-glycoprotein. Trends Biochem. Sci. 25:1-6 (2000).
15. P. Artursson, K. Palm, and K. Luthman. Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv. Drug Deliv. Rev. 46:27-43 (2001).